RECOGNIZING THE MONTH OF JUNE 2026 AS MYASTHENIA GRAVIS AWARENESS MONTH IN THE STATE OF DELAWARE.

153rd General Assembly (2025-2026) Introduced by Jack Walsh and 1 co-sponsor

Declares June 2026 as Myasthenia Gravis Awareness Month in Delaware to educate the public about MG, support affected individuals, and promote related awareness activities.

Passed By Senate. Votes: 18 YES 3 ABSENT

Summary of SCR 194 (Session 153, Delaware)

Purpose and Intent

SCR 194 recognizes and designates the month of June 2026 as Myasthenia Gravis Awareness Month in the State of Delaware. The resolution aims to raise public awareness about myasthenia gravis (MG), a chronic autoimmune neuromuscular disorder that leads to weakness of voluntary muscles.

By declaring an awareness month, the measure seeks to educate Delaware residents about MG, promote understanding and support for individuals affected by the condition, and encourage participation in related health awareness activities.

Key Provisions

Official designation: June 2026 is proclaimed as Myasthenia Gravis Awareness Month in Delaware.

Public awareness objectives: The resolution typically encourages state agencies, organizations, and the public to observe the month with activities that inform and educate about MG, its symptoms (e.g., ptosis, diplopia, generalized muscle weakness, fatigue), treatment options, and the impact on quality of life.

Encouragement to collaborate: Invites relevant stakeholders—healthcare providers, patient advocacy groups, educational institutions, and community organizations—to participate in awareness efforts during June 2026.

Affected Parties

Individuals with myasthenia gravis and their families: Benefit from heightened visibility, resources, and community support highlighted during the awareness month.

Healthcare providers and researchers: May experience increased attention to MG symptoms, diagnosis, and management options, potentially facilitating outreach and education.

State agencies and public institutions: Encouraged to coordinate or support awareness activities (e.g., disseminating information, hosting events).

General public and employers: Gain informational resources about recognizing MG symptoms and supporting affected individuals.

Procedural and Timeline Details

Introduction and passage: The bill was introduced and subsequently passed by the Delaware Senate on May 20, 2026.

Vote tally: Senate passage recorded as 18 votes in favor, with 3 absences.

Next steps: As a concurrent resolution or senate resolution, approval by the Delaware House of Representatives may be required for formal enactment, depending on the chamber's consideration process. If adopted, the designation would take effect in June 2026 and be observed during that month by state entities and the public.

Notes

The resolution does not create new statutory duties or funding assumptions; it primarily serves as an official commendation and public awareness tool.

Specific programs, events, or funding opportunities are not outlined within the text of the summary provided, but the designation commonly triggers partnership opportunities with MG advocacy groups and healthcare providers.

If you’d like, I can add context on myasthenia gravis itself (symptoms, prevalence, treatment options) or compare how similar awareness designations have been implemented in Delaware or other states.